Atlas Trials

A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol

Clinical trial NCT03467113 · COMPLETED

Trial details

NCT number
NCT03467113
Sponsor
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dravet SyndromeLennox Gastaut Syndrome
Start date
2018-01-19
Primary completion
2020-06-24
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.